UnitedHealth Group just got one of its biggest analyst endorsement clusters in recent memory. At least ten firms raised targets on April 22 alone. That single-day sweep tells the story.
The scope of the target increases was notable. Morgan Stanley kept its Overweight and lifted its target from $375 to $395. Wells Fargo went from $370 to $397, maintaining Overweight. RBC Capital moved from $361 to $400. Leerink Partners made the biggest jump in the group — from $345 to $400. Oppenheimer pushed to $405 from $385.
Argus Research went further. It upgraded outright from Hold to Buy, setting a fresh $400 target.
TD Cowen followed on April 23, raising its Hold target from $311 to $337 — more cautious, but still moving higher.
The consensus mean target now stands at $387. The stock closed at $354.69 on April 27. That leaves roughly 9% upside to consensus.
Short interest fell 14.2% over the past week to 1.68% of float. That is a low base — short sellers were not a dominant force in this name. But the speed of the exit is still telling. About 2.5 million fewer shares were borrowed by April 24 compared to a week earlier.
The borrow market reflects this. Cost to borrow sits at 0.38% — essentially frictionless. It briefly spiked to 0.45% on April 24 as the exit accelerated, but quickly eased back. Availability in the lending pool is ample. There is no squeeze dynamic here. The shorts simply left.
The put/call ratio was 0.65 on April 27. That is fractionally below the 20-day mean of 0.66. The PCR z-score is -0.43 — close to neutral. Options traders are not pushing any strong directional bet. Call activity has ticked up modestly over the week, but nothing that signals unusual conviction.
Among the top 15 holders, T. Rowe Price added 3.09 million shares as of March 31. Capital Research added 2.88 million. State Street added 1.12 million. Vanguard added just under 1 million. The direction is consistent across the major passive and active holders.
What to watch: Next earnings are scheduled for June 1. The factor score for analyst recommendation divergence sits at the 98th percentile — Wall Street is more bullish on UNH relative to its own history than almost any other stock. That is a high bar to clear.
See the live data behind this article on ORTEX.
Open UNH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
